John H Stewart
Overview
Explore the profile of John H Stewart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Levine E, Cos H, Votanopoulos K, Shen P, Russell G, Mansfield P, et al.
Ann Surg Oncol
. 2024 Dec;
32(2):711-712.
PMID: 39633167
No abstract available.
2.
Levine E, Cos H, Votanopoulos K, Shen P, Russell G, Mansfield P, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):679-686.
PMID: 39531120
Background: Appendiceal cancer is a rare disease that has proven difficult to study in prospectively. Our initial report of this trial showed minor hematologic toxicity with both mitomycin C and...
3.
King K, Turner J, Stewart J
Am J Surg
. 2022 Mar;
224(1 Pt B):299-301.
PMID: 35282871
No abstract available.
4.
Moaven O, Votanopoulos K, Shen P, Mansfield P, Bartlett D, Russell G, et al.
Ann Surg Oncol
. 2019 Nov;
27(3):772-780.
PMID: 31720933
Background: This study evaluated health-related quality of life (HRQOL) using patient-reported outcomes in subjects with mucinous appendiceal neoplasms who underwent cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as part...
5.
Levine E, Votanopoulos K, Shen P, Russell G, Fenstermaker J, Mansfield P, et al.
J Am Coll Surg
. 2018 Jan;
226(4):434-443.
PMID: 29331663
Background: Appendiceal cancer is a rare disease that has proven difficult to study in prospective trials. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) is an established therapy for peritoneal dissemination...
6.
Votanopoulos K, Shen P, Stewart J, Levine E
Ann Surg Oncol
. 2017 Nov;
24(Suppl 3):602.
PMID: 29134373
No abstract available.
7.
Clark J, Wong M, Kaufman H, Daniels G, Morse M, Mcdermott D, et al.
Clin Genitourin Cancer
. 2016 Dec;
15(1):31-41.e4.
PMID: 27916626
Background: This analysis describes the outcome for patients who received targeted therapy (TT) prior to or following high-dose interleukin-2 (HD IL-2). Patients And Methods: Patients with renal cell carcinoma (n ...
8.
Valente K, Blackham A, Levine E, Russell G, Votanopoulos K, Stewart J, et al.
Am J Surg Pathol
. 2016 Jul;
40(9):1243-8.
PMID: 27438989
Diffuse malignant peritoneal mesothelioma (MPeM) is rare and arises from peritoneal serosal surfaces. Although it shares similar histomorphology with its counterpart, malignant pleural mesothelioma, etiologies, clinical courses, and therapies differ....
9.
Cummins K, Russell G, Votanopoulos K, Shen P, Stewart J, Levine E
J Gastrointest Oncol
. 2016 Mar;
7(1):3-9.
PMID: 26941979
Background: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have shown variability in survival outcomes when used to treat peritoneal surface disease (PSD) from appendiceal and colorectal cancers. The primary...
10.
Mogal H, Levine E, Fino N, Obiora C, Shen P, Stewart J, et al.
Ann Surg Oncol
. 2015 Nov;
23(5):1486-95.
PMID: 26572753
Background: Routine postoperative intensive care unit (ICU) observation of patients undergoing cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) is driven by historically reported morbidity and mortality data. The validity...